Considering our results and these previous findings, it is plausible that CRAMP present at a high concentration in breast cancer, ovarian cancer, and melanoma serves as a key regulator of CD73 induction on tumor-infiltrated T cells together with TGF-β. This evidence concerns the gene TGFB1 and neoplasm.